On Oct 31, major Wall Street analysts update their ratings for $Mondelez International (MDLZ.US)$, with price targets ranging from $76 to $85.
BofA Securities analyst Peter Galbo maintains with a buy rating.
Citi analyst Thomas Palmer maintains with a buy rating, and adjusts the target price from $80 to $78.
Barclays analyst Andrew Lazar maintains with a buy rating, and maintains the target price at $76.
Wells Fargo analyst Christopher Carey maintains with a buy rating, and maintains the target price at $78.
Evercore analyst David Palmer maintains with a buy rating, and adjusts the target price from $79 to $85.
Furthermore, according to the comprehensive report, the opinions of $Mondelez International (MDLZ.US)$'s main analysts recently are as follows:
Following Mondelez's Q3 report, the company's reaffirmation of its full-year forecast suggests a Q4 performance that may not meet previous expectations. Additionally, the firm has indicated that its 2025 earnings could potentially see a decrease compared to the prior year. Adjustments in estimates have been made to account for the impact of cocoa price inflation, yet there remains a possibility of more positive earnings potential in the upcoming year.
Following Mondelez's Q3 results, management continues to project organic growth at the upper end of the 3%-5% range for 2024.
The assessment notes that management acknowledges the challenge in increasing earnings per share (EPS) by 2025, in addition to an expected negative impact on EPS from other factors. Nevertheless, management does not anticipate a significant downturn, merely a difficulty in achieving growth. Given the strength of organic sales and a reasonable valuation based on earnings, the company is expected to attract attention from investors.
Here are the latest investment ratings and price targets for $Mondelez International (MDLZ.US)$ from 8 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美东时间10月31日，多家华尔街大行更新了$亿滋 (MDLZ.US)$的评级，目标价介于76美元至85美元。
美银证券分析师Peter Galbo维持买入评级。
花旗分析师Thomas Palmer维持买入评级，并将目标价从80美元下调至78美元。
巴克莱银行分析师Andrew Lazar维持买入评级，维持目标价76美元。
富国集团分析师Christopher Carey维持买入评级，维持目标价78美元。
Evercore分析师David Palmer维持买入评级，并将目标价从79美元上调至85美元。
此外，综合报道，$亿滋 (MDLZ.US)$近期主要分析师观点如下：
在蒙德利的Q3报告之后，公司重申全年预测，这表明Q4的表现可能不会达到先前的期望。另外，该公司表示，2025年的收益可能会与去年相比出现下降。针对可可价格通胀的影响已进行了估算调整，但仍存在着未来一年更多积极收益潜力的可能性。
在蒙德利的Q3业绩报告后，管理层继续预计2024年有机增长将位于3%-5%区间的高端。
评估指出，管理层承认到2025年提高每股收益(EPS)的挑战，此外还预计EPS将受到其他因素的负面影响。然而，管理层预计并没有明显的衰退，只是在实现增长方面存在困难。考虑到有机销售的增长和基于收益合理估值，预计该公司将吸引投资者的关注。
以下为今日8位分析师对$亿滋 (MDLZ.US)$的最新投资评级及目标价：
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
